TFF Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
TFF Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • TFF Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $901K.
  • TFF Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.01M, a 57.3% decline from 2022.
  • TFF Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $11.8M, a 59.3% decline from 2021.
  • TFF Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $28.9M, a 15.6% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.01M -$6.74M -57.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $11.8M -$17.1M -59.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $28.9M +$3.89M +15.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $25M -$4.05M -14% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $29M +$16.7M +134% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 $12.4M Jan 24, 2018 Dec 31, 2018 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.